Improvement of Facial Discoid Dermatosis With Ustekinumab Treatment

JAMA Dermatol. 2022 Sep 1;158(9):1079-1080. doi: 10.1001/jamadermatol.2022.2478.

Authors

Katelyn J Rypka¹, Travis S Fulk^{2

3}, Alavi Afsaneh⁴, Daniel D Miller^{1

2}, Noah I Goldfarb^{1

2

3

5}

Affiliations

¹ University of Minnesota Medical School, Minneapolis.
² Department of Dermatology, University of Minnesota, Minneapolis.
³ Department of Dermatology, Minneapolis VA Medical Center, Minneapolis.
⁴ Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
⁵ Department of Internal Medicine, Minneapolis VA Medical Center, Minneapolis.

PMID: 35767241
DOI: 10.1001/jamadermatol.2022.2478

No abstract available

MeSH terms

Facial Dermatoses* / diagnosis
Facial Dermatoses* / drug therapy
Humans
Ustekinumab* / therapeutic use

Substances

Ustekinumab